SCHEMBL11297008

SCHEMBL11297008

C[CH][C@H](COCCCCCCCCCCCCCCCCCC)OCCCCCCCCCCCCCCCCCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.47
LPAR1 Q92633 7/20 0.46
LPAR3 Q9UBY5 7/20 0.46
LPAR2 Q9HBW0 4/20 0.46
HTT P42858 2/20 0.46
SPHK1 Q9NYA1 1/20 0.42
DNM1 Q05193 1/20 0.41
PRKD3 O94806 1/20 0.41
PRKCG P05129 1/20 0.41
PRKCB P05771 1/20 0.41
PRKCA P17252 1/20 0.41
PRKCH P24723 1/20 0.41
PRKCI P41743 1/20 0.41
PRKCE Q02156 1/20 0.41
PRKCQ Q04759 1/20 0.41
PRKCZ Q05513 1/20 0.41
PRKCD Q05655 1/20 0.41
PRKD1 Q15139 1/20 0.41
LPAR5 Q9H1C0 4/20 0.40
LPAR6 P43657 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11293584 0.83 LPAR1 (0.49) USP2LPAR1LPAR3LPAR2HTT
SCHEMBL8322731 0.83 USP2 (0.46) USP2LPAR1LPAR3LPAR2HTT
SCHEMBL11293582 0.83 LPAR1 (0.49) USP2LPAR1LPAR3LPAR2HTT
SCHEMBL8677401 0.81 USP2 (0.44) USP2LPAR1LPAR3LPAR2HTT
SCHEMBL7591541 0.81 USP2 (0.43) USP2LPAR1LPAR3LPAR2HTT
SCHEMBL1685011 0.80 USP2 (0.43) USP2LPAR1LPAR3LPAR2HTT
SCHEMBL4204833 0.77 LPAR1 (0.68) USP2LPAR1LPAR3LPAR2HTT
SCHEMBL4879843 0.77 LPAR1 (0.68) USP2LPAR1LPAR3LPAR2HTT
SCHEMBL4294185 0.77 LPAR1 (0.68) USP2LPAR1LPAR3LPAR2HTT
SCHEMBL8636551 0.77 LPAR1 (0.68) USP2LPAR1LPAR3LPAR2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3202760-B1 PEGYLATED LIPIDS AND THEIR USE FOR DRUG DELIVERY ALNYLAM PHARMACEUTICALS INC (US) 2019-08-21 EP disclosed
US-9999673-B2 PEGylated lipids and their use for drug delivery ALNYLAM PHARMACEUTICALS, INC. (US) 2018-06-19 US disclosed
EP-3202760-A1 PEGYLATED LIPIDS AND THEIR USE FOR DRUG DELIVERY Alnylam Pharmaceuticals, Inc. (US) 2017-08-09 EP disclosed
EP-2663548-B1 PEGYLATED LIPIDS AND THEIR USE FOR DRUG DELIVERY ALNYLAM PHARMACEUTICALS INC (US) 2017-04-05 EP disclosed
EP-2663548-A1 PEGYLATED LIPIDS AND THEIR USE FOR DRUG DELIVERY Alnylam Pharmaceuticals, Inc. (US) 2013-11-20 EP disclosed
WO-2012099755-A1 PEGYLATED LIPIDS AND THEIR USE FOR DRUG DELIVERY ALNYLAM PHARMACEUTICALS, INC. (US) 2012-07-26 WO disclosed